- Biomedical Research (2013) Volume 24, Issue 1
Mini Review: Natural ingredients for diabetes which are approved by Korean FDA.Cheolin Park1* and Jae-Sik Lee2
- *Corresponding Author:
- Cheolin Park
Department of Biomedical Laboratory Science
Daegu Health College, (Taejeon-Dong) 15 Youngsong-Ro
Buk-Gu, Daegu 702-722, Korea
Accepted date: November 01 2012
Diabetes mellitus is a condition in which a person has a high blood sugar/glucose level. This is because the body does not produce enough insulin, or because the body cells do not properly respond to the insulin that is produced. Herbal treatment for diabetes has been a part of traditional medicine for thousands of years. The natural herbs for diabetes treatment focus on lowering blood sugar, reducing the damaging effects of the disease and maintaining of a safe, healthy level of blood glucose. Many diabetic patients seeking an alternative treatment to traditional drugs turn to natural herbs for help. This review article provides very useful information of officially-approved antidiabetic natural ingredients [Table 1] by KFDA, thereby providing consumers with a wise decision when they purchase the effective nutraceuticals for diabetes. Therefore, medicinal herbs may be used to prevent and treat diabetes reliably and safely when the government approves the ingredients or products officially.
Diabetes, Medicinal herbs, Nutraceuticals, KFDA, Ingredients
Diabetes is a chronic metabolic disorder of carbohydrates, proteins, and fat due to absolute or relative deficiency of insulin secretion with/without varying degree of insulin resistance [1,2]. It may also be defined as a disease where the body either produces little insulin/ceases to produce insulin or becomes progressively resistant to its action .
Despite of tremendous advancement of medications, many diabetic patients try other means to cure and/or to control diabetes and do get satisfactory results. Among such other means, herbal cure for diabetes is one of the most popular means to deal with diabetes. Herbs from China, India and several countries have been used in place of medication to manage diabetes.
Natural herbs to lower blood sugar typically affect glucose levels in different ways. Although the exact mechanisms and active ingredients are sometimes unknown, many of the herbs contain flavanoids that prevent beta cell damage . Other features of blood sugar lowering herbs may include hypoglycemic agents such as charantin, polypeptide, allyl propyl disulphide and diallyl disulphide oxide. Hundreds of plant species have been studied for their potential blood glucose lowering properties. The better studied botanicals with hypoglycemic activity include Momordica charantia (bitter melon), Trigonella foenum-gracum (fenugreek), Gymnema sylvestre (gurmar), Panax quinquefolius (ginseng), Opuntia streptacanthia (nopal cactus), Aloe barbadenesis (aloe), Vaccinium mytillus (bilberry), Silybum marianum (milk thistle), Allium sativum and Allium cepa (garlic and onions) and Pterocarpus marsupium (Vijayasar).
Most countries regulate and control the use, application, claim, and other parts of medicinal anti-diabetic herbs. In America, conventional foods, functional foods, foods for special dietary use, medical food and dietary supplements are approved, while Japan approves foods for specified health use. Even though herbs have unbelievable antidiabetic effects, FDA forbids any herb to claim that its active ingredient can cure diabetes. Like other countries, the Korean government (KFDA) regulates and controls on all procedures including approval, production, products, claim and the manufacture of all medical herbs, imported or native herbs.
There are three types of functional levels such as Functions I, II and III approved by Korean FDA (Table 2). According to classification, levels can be claimed on the label of the box or elsewhere. However, claims should not include name of the disease like diabetes, which is somewhat restricted and strongly controlled by KFDA. Function I indicates that the ingredient has an effect on lowering glucose level as confirmed with several clinical studies. Function II suggests that the ingredient may be helpful in lowering glucose level also based on some clinical studies. Function III means that the ingredient may be helpful in lowering glucose level but not based on clinical studies. Due to high cost of the conventional medication for diabetes, developing countries are trying to find out alternative solutions from the natural ingredients. Several botanical supplements have been studied as potential therapeutic agents in the management of diabetes and its related complications. This article will briefly review what is known about the efficacy of approved herbs or their ingredients with hypoglycemic activity which is currently used in Korea.
Ingredients approved by Korean fda (KFDA)
The herb, wild yam is considered as one of the most versatile of herbs used to treat hormone-related conditions. Wild yam extract is derived from the root and is often used as a PMS (premenstrual syndrome) remedy today; many patients are using it and have reported relief from menopausal symptoms . The additional benefits of wild yam extract include its anti-inflammatory and muscle relaxing properties. However, no reports have so far been available regarding its anti-diabetic property.
Yam alcohol extract was approved by KFDA in 2011. However, KFDA claimed that the extract effectively regulates blood sugar level with a dose of 900mg/day, but human studies still remain insufficient. Its functional grade remains III, the lowest grade. It may be listed as an antidiabetic ingredient but it has not been fully proven.
Tagatose is a functional sugar. Since it is metabolized differently from sucrose, tagatose has a minimal effect on blood glucose and at the insulin level. Tagatose is sweet like sugar. However, its calorie value is 1.5 calories per gram since less than 20% of ingested tagatose is absorbed in the small intestine . It was approved as a food additive by the FDA in 2003. In prelimnary studies in humans, tagatose has shown a low postprandial blood glucose and insulin response. It has recently been documented that oral d-tagatose attenuates the rise in plasma glucose during an oral glucose tolerance test in subjects with type II diabetes .
KFDA approved its Functional grade as II and daily intake amounts 5~7.5gram/day as D-tagatose. However, KFDA warned that gastric disorder is associated with high intake of D-tagatose. In 2004, Australia and New Zealand issued a warning that people suffering from fructose malabsorption should not eat tagatose.
Hydrolyzed Concentrates of ginseng: Korean Ginseng contains thirteen different ginsenosides. One of them, Panaxans helps to lower blood sugar. The polysaccharide enhances immune system and its antioxidant property is to protect the body from illness, disease and stress.
Ginseng and its saponins have been studied in alloxantreated, genetically diabetic, and normal mice  and revealing its hypoglycemic effect. Ginseng saponins also stimulate the production of insulin. In elderly patients with hyperglycemia, the saponins reduced serum glucose . Ginseng saponins are typically provided in tablets of 50 mg each, with a dose of 1-2 tablets each time, two to three times per day.
KFDA approved ginseng saponins as grade II and the suggested daily intake is 960mg/day as hydrolyzed concentrates of ginseng. However, patients are to be careful when it is taken with other prescribed medicines such as antidiabetic agents and anticoagulants.
Peptide complex from small black soybeans (Rhynchosia Nulubilis)
1. Beans, particularly black beans, are a rich source of antioxidants. Beans with colored seed coats have higher levels of flavonoids, and thus higher antioxidant level. This antioxidant protects and keeps the skin healthy, and also an exerts anti-aging effect.
The small black beans’ powder showed to be hypoglycemic with a corresponding effect on insulin sensitivity in Streptozotocin (STZ)-induced diabetic rats . Recently, there are one clinical study about the effect of black soy peptide supplement on glucose control in subjects with prediabetes (impaired fasting glucose or impaired glucose tolerance) and newly diagnosed with type II diabetes mellitus .
Subjects with fasting glucose (≥110mg/dL) who consumed black soy peptides for 12 weeks showed lower fasting glucose levels and had a significant reduction in 2- hour postload glucose compared with baseline levels. KFDA approved this ingredient as Function III grade. Recommended daily dose is 4.5 gram peptide complex from small black soybeans.
Mixed extracts of Fructus aurantii and Mullberry leaves (Mous alba)
Mullberry leaves are commonly used as oriental medicine in Korea. Mullberry (Morus alba), a herb contains an active ingredient DNJ (1-deoxynojirimycin) which helps in controlling blood sugar level by inhibiting carbohydrate digestion and absorption [12,13]. Fructus aurantii or Fructus aurantii immaturus, called bitter orange is bitter and pungent in flavor. There is no scientific data about anti-diabetic effect of Fructus aurantii when its extract is used alone.
However, combined extract of Fructus aurantii and mullberry leaves showed blood sugar lowering effect in Streptozotocin- induced type II diabetes model  and in type II diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats , respectively. Prevention of diabetesrelated cardiovascular complications by using a mixture of the same herbal extracts has also been claimed. Based on scientific evidence KFDA recommended extracts of these herbal combination as Function II grade at a dose of 2.8 gm/day.
Powder of lyophilized silkwormSilkworm powder has inhibitory effects on glucose absorption  in human intestinal epithelial cells. Silkworm powder inhibits α-glucosidase activation and glucose transporter (SGLT1) expression. These results suggest that silkworm powder can be used as a natural functional food for the prevention and alleviation of type-II diabetes mellitus [17,18].
KFDA approved lyophilized silkworm powder as Function II grade and recommended intake amounts 2.7gram/day. as powder of lyophilized silkworm. However, KFDA warned that this is not applied for diabetic treatment r prevention and you need to consult your physician prior to use before taking this.
Nopal Opuntia streptacantha Lemaire (nopal cactus) extract
Opuntia streptacantha Lemaire, also referred to as nopal/prickly pear cactus, is a member of the family cacti commonly used as food and medicinal plant in Central and South America. Both the sap and the leaves of the cactus, Opuntia streptacanthia Lemaire have been studied for their blood glucose lowering properties in animal models or subjects with type II diabetes .
The use of Opuntia streptacantha Lemaire as a treatment for diabetes has been tested in subjects with type II diabetes. . Studies have not been well designed and the mechanism of blood glucose lowering action of the herb has not been suggested. Since nopal is a good source of fiber and pectin, it is believed to act primarily by decreasing glucose absorption in the gastrointestinal tract . A recent study with adult-onset diabetics in Mexico showed that nopal has hypoglycemic effect on the obese. simultaneously lowers serum levels of low-density cholesterols and triglycerides .
KFDA approved the grade of Napol as Function II. 4.3gram/day as water-soluble fiber of Nopal extract has been recommeded. However, pregnant or lactating women and children should not go for it.
Extracts of fermented soybean
This product is an aqueous extract of fermented bean (Glycine max.) with Aspergilus oryzea. It is standardized with IC50 0.018~0.1mg/ml as high maximal inhibitory concentration of Tris (2-Amino-2-(hydroxymethyl)-1,3- propanediol) and alpha-Glucosidase. This Tris functions as alpha-Glucose inhibitor, which inhibits glucose absorption. Study with extract of fermented soybean confirmed that blood glucose level and HbA1C are decreased for a longer period of time . KFDA approved this preparation as Function II and its intake of 900mg/day as extracts of fermented soybean has been recommended.
Pine tree essence
Pine needle (Pinus densiflora Sieb. et Zucc.) extract is being used for many, many years for treating multiple ailments in Asia Pacific region. The extract is a composite mixture of a number of organic compounds. Three primary components standardized by KFDA are 3-carene (12%), limonene (8%) and terpinolene (17.5%), respectively. This product is prepared by steaming needles of Pinus densiflora with a distiller. Consistent results of controlling blood glucose levels in streptozotocin-induced diabetic rats are evident  but no clinical studies have so far been recorded.
KFDA approved the preparation as Function II grade and the distilled concentrates of pine needles of 1350mg/day has been recommended. . However, persons having bronchial asthma, chronic cough or inflammation of airways are strictly restricted from using this preparation.
Non-fat Seeds alcohol extract from Oenothera biennis (Evening primrose)
Evening primrose oil found in the plant's seeds is rich in the essential fatty acid gamma-linolenic acid (GLA). Essential fatty acids -- such as omega-6, found in EPO, and omega-3, found in fish oil are used as building blocks for a number of molecules in the body.
Evening primrose extract has inhibitory efficacy on α- amylase and α-glucosidase. One of Japanese pharmaceuticals performed a trial on the efficacy of tablet containing evening primrose extract for 12 weeks on 44 male subjects After taking the tablets for 12 weeks, fasting blood glucose levels were significantly lowered and HbA1c value was also decreased .
KFDA regulated the polyphenol (60-70%) and Petan-Ogalloyllbeta- D-glucose (2-2.8%) as core ingredients. This extract inhibits the intestinal enzyme alpha-glucosidase. When alpha-glucosidase is inhibited, carbohydrate absorption is slowed down, thereby reducing the rise in blood sugar following a meal. KFDA approved the preparation as Function II grade standardized and recommended the dosage as whole extract of 200-300mg/day.
Guava leaf (Psidium Gujava) extract
This extract is prepared by hot water and core ingredient, 17% of total polyphenol (strictinin, isostrictinin) is approved by KFDA. Deguchi et al.  demonstrated that Guava leaf hot water extract inhibits in vitro activities of maltase, sucrase, and alpha-amylase in a dose-dependent manner. Recently, Shen et al. have reported that longterm feeding of guava leaf extract in diabetic rats significantly reduced blood glucose and increased levels of plasma insulin.. A crossover clinical trial involving 20 hospitalized patients with T2DM was conducted to compare the potentiality of Guava Leaf Tea and voglibose (Basen®;Takeda Chemical Industries, Ltd., Tokyo, Japan) to reduce postprandial blood glucose elevation . The recommended dose is 123.5mg/day with polyphenol and approved as Function II grade.
Mixture of Rhodiola rosea and Cinnamon bark
Kwon et al  reported that Rhodiola spp. Inhibits activity of alpha-amylaste, alpha-glucosidase and angiotensin converting enzyme (ACE), indicating that Rhodiola spp. can manage type II diabetes as well as hypertension.. Cinnamon has been used medicinally for a long time. A study was conducted with 60 men and women with Type II diabetes. The participants took either 1.0, 3.0, or 6.0 gm/day of cassia cinnamon or a placebo for 40 days. Blood glucose levels of the patients dropped between 18% and 29%. However, dosage of 1.0 gram/day did not show any significant effect.
The results suggest that the inclusion of cinnamon in the diet of people with type II diabetes reduces risk factors associated with diabetes and cardiovascular diseases . This formulation mixture consists of 88.9% of Rhodiola rosea extract and 11.1% of Cinnamon Bark extract. The key ingredients are 1.5% of salidroside and 0.2% of cinnamic acid, respectively. KFDA approved that this mixture has a mild effect in controlling fasting blood sugar but lack of scientific data made the mixture as function III grade. The recommended dose of the mixture for its safe use is 900mg/day.
Pinitol is a sweet crystalline compound that is extracted from the heartwood of sugar pine. D-pinitol (3-O-methylchiroinositol), an active principle of the traditional antidiabetic plant, Bougainvillea spectabilis, is claimed to exert insulin-like effects. The antidiabetic effects were studied in streptozotocin (STZ)-induced diabetic Wistar rats , in 15 human with type II diabetes  and in obese subjects with soybean-derived pinitol supplementation . Results of the studies suggest that pinitol supplementation may be useful in controlling postprandial increase in blood glucose. KFDA approved pinitol as Function III grade with dosage of 1200mg/ day.
Banaba alcohol extract
Park and Lee  have reviewed antidiabetic efficacy of banaba. Corosolic acid, one of the primary components of banaba extract which induces GLUT4 (Glucose Transporter) transloca-tion in diabetic mice . The hypoglycemic effects in several human studies were shown with standard extract of L. speciosa leaves , with banaba tablet containing banaba extract on mild type II diabetic patients , with banaba extract on diabetic patients with one-year clinical study  and with corosolic acid .
KFDA approved blood glucose lowering effects of banaba alcohol extract as function II grade with a restricted dose of 50-100 mg/day corosolic acid. However, KFDA has also suggested that this ingredient should not be used in the prevention of diabetes.
Diabetes mellitus, a disorder of carbohydrate metabolism characterized by hyperglycemia has increasingly become a growing concern in the world. Diabetes develops when there is a defect in the secretion of insulin or a defect in the action of insulin or both . Uncontrolled high blood glucose levels can cause long-term damage to both large and small blood vessels and nerves, leading to unavoidable organ failure. To prevent possible damage to various organs, most diabetic patients remain on several antidiabetic medications. Unfortunately, various adverse effects such as heart failure, hypoglycemia, kidney failure and weight gain are reported following chronic use of prescribed medicines. Due to various reported side effects, many scientists have been seeking the substitution of antidiabetic drugs to natural remedies which have hypoglycemic potency [39,40]. In the review article, Park and Lee  has emphasized banaba as one of powerful natural ingredients having hypoglycemic potency. Several hundreds of medicinal plants species have efficacy for reducing blood sugar level, Herbs are used to manage Type I and Type II diabetes and their complications. The abovementioned plants and ingredients approved by KFDA have been considered for their possible hypoglycaemic actions. Further scientific investigations on KFDA recommended herbal ingredients can provide appropriate information on trustful guidelines to consumers in choosing herbal nutraceuticals for diabetes.
The beauty of herbs is that they don't cause any serious health problems. Patients need to get a professional medical opinion before using a particular herbal antidiabetic treatment. However, appropriate diet and physical exercise along with herbal medication is a healthy combination for diabetic patients.
- Barar FSK. Essentials of Pharmacotherapeutics. 3rd ed. S.Chand and Company Ltd: New Delhi; 2000.
- Devlin MT. Text book of Bio Chemistry. 4th edn. Wileyliss Inc: NewYork; 1997.
- Ranjan C, Ramanujam R. Diabetes and insulin resistance associated disorders: Disease and the therapy. Curr Sci 2002; 83: 1533-1538.
- Park C, Lee JS. Banaba. The natural remedy as antidiabetic drug. Biomed Res 2011; 22: 125-129.
- Komesaroff PA, Black CV, Cable V, Sudhir K. Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopasusal women. Climacteric 2001; 4: 144-150.
- Lu Y, Levin GV, Donner Tagatose TW. A new antidiabetic and obesity control drug Diabetes, Obesity and Metabolism 2008;10: 109-134.
- Donner TW, Magder LS, Zarbalian K. Dietary supplymentation with d-tagatose in subjects with type II diabetes leads to weight loss and raised high-density lipoprotein cholesterol. Nutr Res 2010; 12: 801-806.
- Kimura M, Suzuki J, The pharmacological role of ginseng in the blend effect of traditional Chinese medicines in hyperglycemia. Advances of Chinese Medicinal Materials Research, World Scientific, Singapore. 1985.
- Chen KJ, Zhang WP, Advances on antiaging herbal medicines in China, Abstracts of Chinese Med 1987; 1: 309-330.
- Lee DH, Kwak DH, Kim SM, Ju EJ, Choi HG, Kim OH, Hwang JB, Bae NG, Jung KY, Han JC, Park HD, Choo YK. Effect of Small Black Soybean Powder on Blood Glucose and Insulin Sensitivity in Streptozotocin-Induced Diabetic Rats. J Korean Soc Food Sci Nutr 2004; 33: 1618-1625.
- Kwak JH, Lee JH, Ahn CW, Park SH, Shim ST, Song YD, Han EN, Lee KH Chae JS. Black soy peptide supplementation improves glucose control in subjects with prediabetes and newly diagnosed type II diabetes mellitus. J Med Food 2010; 13: 1307-1312.
- Kim SY, Gao JJ, Lee WC. Antioxidative flavonoids from the leaves of Morus alba. Arch Pharm Res 1999; 22: 81-85.
- Kimura T, Nakagawa K, Kubota H. Food-Grade Mulberry Powder Enriched with 1-Deoxynojirimycin Suppresses the Elevation of Postprandial Blood Glucose in Humans. J Agric Food Chem 2007; 55: 5869-5874.
- Park JS, Park CH, Jun C, Choi Y, Hwang G, Kim D. The anti-diabetes and vasoelasticity effect of Mori Folium and Aurantii Fructus in Streptozotocin induced type II Diabetes Mellitus Model. Korean J Orient Int Med 2007; 28:544-559.
- Kim JH, Chung HS, Kang M, Kim Y, Kim BS, Kim YS, Bae H. (2011) Anti-diabetic effect of standardized herbal formula PM021 consisting of Mori Folium and Aurantii Fructus on type II diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Diabetes Res Clin Pract 2011; 93: 198-204.
- Kang-Sun R, Lee, H-S; Kim I. Effects and Mechanisms of Silkworm Powder as a Blood Glucose-Lowering Agent. Int J Indust Entomol 2002;4; 93-100.
- Han J. Susumu Inoue, Hiroko Isoda. Effects of silkworm powder on glucose absorption by human intestinal epithelial cell line Caco-2. J Nat Med 2007; 61: 387-390.
- Cho MR, Choue R, Chung SH, Ryu JW. Effects of silkworm powder on blood glucose and lipid levels in NIDDM (type II) patients. Korean J Nutr 1998; 31: 1139-1150.
- Ibanez-Camacho R, Meckes-Lozoya M, Mellado-Campos V. The hypoglycemic effects of Opuntia steptacantha studied in different experimental models. J Ethnopharm 1983; 7: 175-181.
- Frati AC, Gordillo BE, Altamirano P, Ariza R. Hypoglycemic effects of Opuntia steptacantha Lemaire in NIDDM. Diabetes Care 1988; 11: 63-66.
- Frati-Munari AC, Yever-Garces A, Becerril M, Islas S, Ariza R. Studies on the mechanism of hypoglycaemic effect of nopal (opuntia sp). Arch Invest Med (Mex) 1987; 18: 7-12.
- Kwon DY, Daily JW 3rd, Kim HJ, Park S. Antidiabetic effects of fermented soybean products on type II diabetes. Nutr Res 2010; 30:1-13.
- Kim SH, Hwang SY, Park OS, Kim MK, Chung YJ. Effect of Pinus densiflora extract on blood glucose level, OGTT and biochemical parameters in Streptozotocin-induced diabetic rats. J Korean Soc Food Sci Nutr 2005; 34: 973-979.
- Takashige K, Koichiro H, Hiroyuki K, Yasuhiro A, Kiyohiko M, Noriaki K, Satoshi M, Kenji T. Effects of single intake of tablets containing Evening Primrose seed extract on postprandial blood glucose levels and long-term effects on fasting blood glucose levels and safety profile of once-daily tablets. J Nutritional Food 2002; 5: 234-241.
- Deguchi Y, Osada K, Uchida K, Kimura H, Yoshikawa M, Kudo T, Yasui H, Watanuki M. Effects of extract of guava leaves on the development of diabetes in the db/db mouse and on the postprandial blood glucose of human subjects. Nippon Nogeikagaku Kaishi 1998; 72:923-932. (Japanese)
- Shen SC, Cheng FC, Wu NJ: Effect of guava (Psidium guajava Linn.) leaf soluble solids on glucose metabolism in type II diabetic rats. Phytother Res 2008; 22:1458-1464.
- Ishibashi K, Oka M, Hachiya M, Maeda T, Tajima N: Comparison of voglibose and Guava Tea (Bansoureicha ®) on postprandial blood glucose level. J Pract Diabetes 2004; 21: 455-458. (Japanese)
- Kwon YI, Jang HD, Shetty K Evaluation of Rhodiola crenulata and Rhodiola rosea for management of type II diabetes and hypertension. Asia Pac J Clin Nutr 2006; 15: 425-432.
- Khan A, Safdar M, Ali Khan MM, Khattak KN, Anderson RA. Cinnamon Improves Glucose and Lipids of People With Type II Diabetes Diabetes Care 2003; 26:215-218.
- Geethan PK Prince PS. Antihyperlipidemic effect of Dpinitol on streptozotocin-induced diabetic wistar rats J Biochem Mol Toxicol 2008; 22: 220-224.
- Min-Jung Kang, Jung-In Kim, Sang-Yeon Yoon, Jae Cherl Kim, In-June Cha Pinitol from Soybeans Reduces Postprandial Blood Glucose in Patients with Type II Diabetes Mellitus. J Medicinal Food 2006; 9: 182-186.
- Davis A. Christiansen M. Horowttz J. Klein S. Hellerstien M. Ostlund R. Effect of Pinitol Treatment on Insulin Action in Subjects With Insulin Resistance Diabetes Care 2000; 23: 1000-1005.
- Miura T, Itoh Y, Kaneko T, Ueda N, Ishida T, Fukushima M, Matsuyama F, Seino Y. Corosolic acid induces GLUT4 translocation in genetically type II diabetic mice. Biol Pharm Bull 2004; 27: 1103-1105.
- Judy WV, Hari SP, Stogsdill WW, Judy JS, Naguib YMA, Passwater R. Antidiabetic activity of a standardized extract (Glucosol™) from Lagerstroemia speciosa leaves in type II diabetics: A dose-dependence study. J Ethnopharmacol 2003; 87: 115-117.
- Ikeda Y, Chen JT, Matsuda T. Effectiveness and safety of banabamin tablet containing extract from ba-naba in patients with mild type II diabetes. Japan Pharmacol Ther 1999; 27: 829-835. (Japanese)
- Ikeda Y, Noguchi M, Kishi S, Masuda K, Kusumoto A, Zeida M, Abe K, and Kiso Y. Blood glucose controlling effects and safety on single and long-term administration on the extract of Banaba leaves. J Nutr Food 2002; 5: 41-53. (Japanese)
- Fukushima M, Matsuyama F, Ueda N, Egawa K, Takemoto J, Kajimoto Y, Yonaha N, Miura T, Kaneko T, Nishi Y, Mitsui R, Fujita Y, Yamada Y, Seino Y. Effects of corosolic acid on postchallenge plasma glucose levels. Diabetes Res Clin Pract 2006; 73: 174-177.
- Canadian Diabetes Association 2009. www.diabetes.ca
- Natural Standard Research Collaboration: The Authority on Integrative Medicine. 2007. www.naturalstandard.com
- Nahas R, Moher M. Complementary and alternative medicine for the treatment of type II diabetes. Can Fam Physician 2009; 55: 591-596.